Home LiteratureArticle Details
PMID: 12595458 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Attenuated virulence of a Burkholderia cepacia type III secretion mutant in a murine model of infection.

Infection and immunity ·Vol. 71 ·No. 3 ·2003-03-00 ·Pages 1405-15

Tomich M, Griffith A, Herfst CA, Burns JL, Mohr CD

Abstract

Type III secretion systems are utilized by a number of gram-negative bacterial pathogens to deliver virulence-associated proteins into host cells. Using a PCR-based approach, we identified homologs of type III secretion genes in the gram-negative bacterium Burkholderia cepacia, an important pulmonary pathogen in immunocompromised patients and patients with cystic fibrosis. One of the genes, designated bscN, encodes a member of a family of ATP-binding proteins believed to generate energy driving virulence protein secretion. Genetic dissection of the regions flanking the bscN gene revealed a locus consisting of at least 10 open reading frames, predicted to encode products with significant homology to known type III secretion proteins in other bacteria. A defined null mutation was generated in the bscN gene, and the null strain and wild-type parent strain were examined by use of a murine model of B. cepacia infection. Quantitative bacteriological analysis of the lungs and spleens of infected C57BL/6 mice revealed that the bscN null strain was attenuated in virulence compared to the parent strain, with significantly lower bacterial recovery from the lungs and spleens at 3 days postinfection. Moreover, histopathological changes, including an inflammatory cell infiltrate, were more pronounced in the lungs of mice infected with the wild-type parent strain than in those of mice infected with the isogenic bscN mutant. These results implicate type III secretion as an important determinant in the pathogenesis of B. cepacia.

MeSH Terms
Animals Burkholderia Infections/etiology,pathology Burkholderia cepacia/genetics,metabolism,pathogenicity DNA, Bacterial/analysis Disease Models, Animal Lung/pathology Mice Mice, Inbred C57BL Mutation Virulence
Chemicals
DNA, Bacterial
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Tomich Mladen
Department of Microbiology, University of Minnesota, Minneapolis, Minnesota 55455-0312, USA.
Griffith Adam
Herfst Christine A
Burns Jane L
Mohr Christian D
References (57)
57 references, click to expand
  1. Intracellular survival of Burkholderia cepacia complex isolates in the presence of macrophage cell activation.
    Microbiology. 1999 Dec;145 ( Pt 12):3465-75 PMID: 10627044
  2. Invasion and intracellular survival of Burkholderia cepacia.
    Infect Immun. 2000 Jan;68(1):24-9 PMID: 10603364
  3. Modulation of host immune responses, induction of apoptosis and inhibition of NF-kappaB activation by the Bordetella type III secretion system.
    Mol Microbiol. 2000 Mar;35(5):991-1004 PMID: 10712682
  4. Cepacia syndrome occurring following prolonged colonisation with Burkholderia cepacia.
    Aust N Z J Med. 2000 Apr;30(2):288-9 PMID: 10833131
  5. Assembly and function of type III secretory systems.
    Annu Rev Microbiol. 2000;54:735-74 PMID: 11018143
  6. Preferential adherence of cable-piliated burkholderia cepacia to respiratory epithelia of CF knockout mice and human cystic fibrosis lung explants.
    J Med Microbiol. 2000 Oct;49(10):875-85 PMID: 11023184
  7. Spa33, a cell surface-associated subunit of the Mxi-Spa type III secretory pathway of Shigella flexneri, regulates Ipa protein traffic.
    Infect Immun. 2001 Apr;69(4):2180-9 PMID: 11254573
  8. Invasion of human type II pneumocytes by Burkholderia cepacia.
    Microb Pathog. 2001 Mar;30(3):167-70 PMID: 11273742
  9. Characterization of the type III secretion locus of Bordetella pertussis.
    Int J Med Microbiol. 2001 Mar;290(8):693-705 PMID: 11310448
  10. Type III export: new uses for an old pathway.
    Mol Microbiol. 2001 Apr;40(2):284-93 PMID: 11309112
  11. Burkholderia cepacia genomovar VI, a new member of the Burkholderia cepacia complex isolated from cystic fibrosis patients.
    Int J Syst Evol Microbiol. 2001 Mar;51(Pt 2):271-9 PMID: 11321071
  12. Lipopolysaccharide of Burkholderia cepacia and its unique character to stimulate murine macrophages with relative lack of interleukin-1beta-inducing ability.
    Infect Immun. 2001 Jun;69(6):3663-9 PMID: 11349028
  13. Cellular aspects of Burkholderia cepacia infection.
    Microbes Infect. 2001 Apr;3(5):425-35 PMID: 11369280
  14. Immunolocalisation of Burkholderia cepacia in the lungs of cystic fibrosis patients.
    J Med Microbiol. 2001 Jun;50(6):535-46 PMID: 11393291
  15. Invasion of murine respiratory epithelial cells in vivo by Burkholderia cepacia.
    J Med Microbiol. 2001 Jul;50(7):594-601 PMID: 11444769
  16. Enhanced susceptibility to pulmonary infection with Burkholderia cepacia in Cftr(-/-) mice.
    Infect Immun. 2001 Aug;69(8):5138-50 PMID: 11447196
  17. A putative type III secretion gene cluster is widely distributed in the Burkholderia cepacia complex but absent from genomovar I.
    FEMS Microbiol Lett. 2001 Sep 11;203(1):103-8 PMID: 11557147
  18. Taxonomy and identification of the Burkholderia cepacia complex.
    J Clin Microbiol. 2001 Oct;39(10):3427-36 PMID: 11574551
  19. Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans.
    Clin Infect Dis. 2001 Nov 1;33(9):1469-75 PMID: 11588691
  20. Correlation between an in vitro invasion assay and a murine model of Burkholderia cepacia lung infection.
    Infect Immun. 2002 Mar;70(3):1081-6 PMID: 11854186
  21. Role of flagella in host cell invasion by Burkholderia cepacia.
    Infect Immun. 2002 Apr;70(4):1799-806 PMID: 11895941
  22. Interaction of cblA/adhesin-positive Burkholderia cepacia with squamous epithelium.
    Cell Microbiol. 2002 Feb;4(2):73-86 PMID: 11896764
  23. Patterns of epithelial cell invasion by different species of the Burkholderia cepacia complex in well-differentiated human airway epithelia.
    Infect Immun. 2002 Aug;70(8):4547-55 PMID: 12117967
  24. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem.
    J Pediatr. 1984 Feb;104(2):206-10 PMID: 6420530
  25. Distantly related sequences in the alpha- and beta-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold.
    EMBO J. 1982;1(8):945-51 PMID: 6329717
  26. Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis. Risk factors and outcomes.
    Chest. 1987 Apr;91(4):527-32 PMID: 3829745
  27. Ribotype analysis of Pseudomonas cepacia from cystic fibrosis treatment centers.
    J Pediatr. 1988 Nov;113(5):859-62 PMID: 2903229
  28. Binding of Pseudomonas cepacia to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis.
    J Clin Invest. 1992 Feb;89(2):648-56 PMID: 1371125
  29. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis.
    Lancet. 1993 Jul 3;342(8862):15-9 PMID: 7686239
  30. Nonpolar mutagenesis of the ipa genes defines IpaB, IpaC, and IpaD as effectors of Shigella flexneri entry into epithelial cells.
    J Bacteriol. 1993 Sep;175(18):5899-906 PMID: 8376337
  31. YscN, the putative energizer of the Yersinia Yop secretion machinery.
    J Bacteriol. 1994 Mar;176(6):1561-9 PMID: 8132449
  32. Linkage analysis of geographic and clinical clusters in Pseudomonas cepacia infections by multilocus enzyme electrophoresis and ribotyping.
    J Clin Microbiol. 1994 Apr;32(4):924-30 PMID: 7517953
  33. Cable (cbl) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers.
    J Bacteriol. 1995 Feb;177(4):1030-8 PMID: 7532166
  34. Isolation of a temperate bacteriophage encoding the type III effector protein SopE from an epidemic Salmonella typhimurium strain.
    Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9845-50 PMID: 10449782
  35. Role of ornibactin biosynthesis in the virulence of Burkholderia cepacia: characterization of pvdA, the gene encoding L-ornithine N(5)-oxygenase.
    Infect Immun. 1999 Sep;67(9):4443-55 PMID: 10456885
  36. Biological activity of Burkholderia (Pseudomonas) cepacia lipopolysaccharide.
    FEMS Immunol Med Microbiol. 1995 Apr;11(2):99-106 PMID: 7640678
  37. Enteropathogenic Escherichia coli contains a putative type III secretion system necessary for the export of proteins involved in attaching and effacing lesion formation.
    Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):7996-8000 PMID: 7644527
  38. Requirement for exported proteins in secretion through the invasion-associated type III system of Salmonella typhimurium.
    Infect Immun. 1996 Sep;64(9):3524-31 PMID: 8751894
  39. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia.
    Microbiol Rev. 1996 Sep;60(3):539-74 PMID: 8840786
  40. Invasion of respiratory epithelial cells by Burkholderia (Pseudomonas) cepacia.
    Infect Immun. 1996 Oct;64(10):4054-9 PMID: 8926068
  41. Induction of biologically active interleukin-8 from lung epithelial cells by Burkholderia (Pseudomonas) cepacia products.
    Infect Immun. 1997 Feb;65(2):617-22 PMID: 9009321
  42. The Yersinia Yop virulon: a bacterial system for subverting eukaryotic cells.
    Mol Microbiol. 1997 Mar;23(5):861-7 PMID: 9076724
  43. The invasion-associated type III system of Salmonella typhimurium directs the translocation of Sip proteins into the host cell.
    Mol Microbiol. 1997 May;24(4):747-56 PMID: 9194702
  44. The type III (Hrp) secretion pathway of plant pathogenic bacteria: trafficking harpins, Avr proteins, and death.
    J Bacteriol. 1997 Sep;179(18):5655-62 PMID: 9294418
  45. ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury.
    Mol Microbiol. 1997 Aug;25(3):547-57 PMID: 9302017
  46. Priming of neutrophil respiratory burst activity by lipopolysaccharide from Burkholderia cepacia.
    Infect Immun. 1997 Oct;65(10):4281-7 PMID: 9317038
  47. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov.
    Int J Syst Bacteriol. 1997 Oct;47(4):1188-200 PMID: 9336927
  48. Siderophore production by cystic fibrosis isolates of Burkholderia cepacia.
    Infect Immun. 1998 Feb;66(2):874-7 PMID: 9453660
  49. PepA, a secreted protein of Pseudomonas aeruginosa, is necessary for cytotoxicity and virulence.
    Mol Microbiol. 1998 Feb;27(4):807-18 PMID: 9515706
  50. Type III protein secretion systems in bacterial pathogens of animals and plants.
    Microbiol Mol Biol Rev. 1998 Jun;62(2):379-433 PMID: 9618447
  51. The BvgAS virulence control system regulates type III secretion in Bordetella bronchiseptica.
    Mol Microbiol. 1998 Jun;28(5):945-59 PMID: 9663681
  52. Burkholderia cepacia. Management issues and new insights.
    Clin Chest Med. 1998 Sep;19(3):473-86, vi PMID: 9759550
  53. Genes encoding putative effector proteins of the type III secretion system of Salmonella pathogenicity island 2 are required for bacterial virulence and proliferation in macrophages.
    Mol Microbiol. 1998 Oct;30(1):163-74 PMID: 9786193
  54. Macrophage-dependent induction of the Salmonella pathogenicity island 2 type III secretion system and its role in intracellular survival.
    Mol Microbiol. 1998 Oct;30(1):175-88 PMID: 9786194
  55. The Xanthomonas Hrp type III system secretes proteins from plant and mammalian bacterial pathogens.
    Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9368-73 PMID: 10430949
  56. The bacterial flagellum: reversible rotary propellor and type III export apparatus.
    J Bacteriol. 1999 Dec;181(23):7149-53 PMID: 10572114
  57. Effector proteins of phytopathogenic bacteria: bifunctional signals in virulence and host recognition.
    Curr Opin Microbiol. 2000 Feb;3(1):73-8 PMID: 10679421
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
2003-03-00
Pages
1405-15
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC148827
Subset
IM
Grants
NHLBI NIH HHS · R01 HL065898 · United States
NHLBI NIH HHS · R01 HL65898 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]